Please use this identifier to cite or link to this item:
Title: Effect of truncation on antifungal properties of tetrabranched peptides.
Authors: Chang, Jamie Ya Ting.
Keywords: DRNTU::Science::Biological sciences
Issue Date: 2012
Abstract: Ocular fungal infections are worldwide health concern, resulting in a need to develop new drugs with greater effectiveness. B4010, a tetrabranched antifungal peptide that permeabilizes cytoplasmic membranes, was developed in Prof. Roger Beuerman’s lab. The aims of this project were to determine the effect of structural truncation on the antifungal properties of B4010 tested against five Candida albicans strains and evaluate their therapeutic potential for topical and systemic fungal infections. The effects of truncation were tested with minimum inhibitory concentration (MIC) and membrane permeability via SYTOX green assay. The therapeutic potential was determined via cell viability in 50% tear fluid and MIC in 5% sera. B4010 and its analogues (except B4010∆1-4) showed strong antifungal properties against all five strains. Further analysis demonstrated that the number of amino acids in the repeats contributes to antifungal potency. To maintain optimum antifungal properties, a minimum net charge of +20 and hydrophobicity of -2.1 kcal/mol is required. However, serum stability and candidacidal activity in tear fluid results suggested that shorter copy lengths may be better than longer analogues. This study has presented an optimization profile of B4010 and its analogues that would enable the development of a new class of therapeutically important antifungal compounds.
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SBS Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
  Restricted Access
1.44 MBAdobe PDFView/Open

Page view(s) 50

checked on Oct 21, 2020

Download(s) 50

checked on Oct 21, 2020

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.